Min Xiao

9.2k total citations · 2 hit papers
199 papers, 4.6k citations indexed

About

Min Xiao is a scholar working on Oncology, Molecular Biology and Hematology. According to data from OpenAlex, Min Xiao has authored 199 papers receiving a total of 4.6k indexed citations (citations by other indexed papers that have themselves been cited), including 88 papers in Oncology, 75 papers in Molecular Biology and 47 papers in Hematology. Recurrent topics in Min Xiao's work include CAR-T cell therapy research (36 papers), Lymphoma Diagnosis and Treatment (26 papers) and Immune Cell Function and Interaction (22 papers). Min Xiao is often cited by papers focused on CAR-T cell therapy research (36 papers), Lymphoma Diagnosis and Treatment (26 papers) and Immune Cell Function and Interaction (22 papers). Min Xiao collaborates with scholars based in China, United States and Switzerland. Min Xiao's co-authors include Meenhard Herlyn, Katherine L. Nathanson, Clemens Krepler, Patricia Brafford, Keiran S.M. Smalley, Jianfeng Zhou, Arjun Raj, Katrin Sproesser, Benjamin Emert and Keith T. Flaherty and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Circulation.

In The Last Decade

Min Xiao

182 papers receiving 4.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Rare cell variability and drug-induced reprogramming as a mode of cancer drug resistance

2017 756 citations Clemens Krepler, Katrin Sproesser et al. profile →
Enhancing CD8+ T Cell Fatty Acid Catabolism within a Metabolically Challenging Tumor Microenvironment Increases the Efficacy of Melanoma Immunotherapy

2017 481 citations Gao Zhang, Ravi K. Amaravadi et al. profile →

Peers

Min Xiao

ONCOL

IMMUN

PFM

Clemens A. Schmitt Germany

Christina M. Annunziata United States

Ann Zeuner Italy

Min H. Kang United States

Stanley Lipkowitz United States

Daniel J. Lindner United States

Alberto Ballestrero Italy

Adam S. Asch United States

Hans Christian Reinhardt Germany

Luigi Marchionni United States

Clemens A. Schmitt Germany

Min Xiao

4.3k ×1.6

2.4k ×1.3

ONCOL

1.2k ×1.2

IMMUN

1.0k ×1.3

438 ×0.9

PFM

Citations per year, relative to Min Xiao Min Xiao (= 1×) peers Clemens A. Schmitt

Countries citing papers authored by Min Xiao

Since Specialization

Citations

This map shows the geographic impact of Min Xiao's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Min Xiao with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Min Xiao more than expected).

Fields of papers citing papers by Min Xiao

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Min Xiao. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Min Xiao. The network helps show where Min Xiao may publish in the future.

Co-authorship network of co-authors of Min Xiao

This figure shows the co-authorship network connecting the top 25 collaborators of Min Xiao. A scholar is included among the top collaborators of Min Xiao based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Min Xiao. Min Xiao is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Deng, Xinyue, Qiang Gao, Ke Shen, et al.. (2024). Imbalanced Expression of TACI Isoforms Regulated By TNFRSF13B Variants Promotes the Progression of Epstein-Barr Virus-Associated Lymphoproliferative Diseases. Blood. 144(Supplement 1). 125–125.

Wang, Rong, Yuan Zhang, Minghui Duan, et al.. (2024). Development and validation of a deep learning model for morphological assessment of myeloproliferative neoplasms using clinical data and digital pathology. British Journal of Haematology. 206(2). 596–606. 1 indexed citations

Gao, Xiong, Miaomiao Yang, Lei Li, et al.. (2024). Genetic association of lipid-lowering drugs with aortic aneurysms: a Mendelian randomization study. European Journal of Preventive Cardiology. 31(9). 1132–1140. 4 indexed citations

Chen, Xi, Lei Ji, Min Xiao, et al.. (2024). Evolution and prognostic significance of HER-2 changes from primary to residual disease in patients with HER-2–negative breast cancer receiving neoadjuvant chemotherapy.. Journal of Clinical Oncology. 42(16_suppl). 583–583.

Zhang, Pengxiang, et al.. (2024). Green Synthesis of Gold Nanoparticles for Catalytic Reduction of 4-Nitrophenol and Methylene Blue for Sustainable Development. 2(1). 10002–10002. 6 indexed citations

Zhang, Shiyuan, et al.. (2024). A single‐centre, real‐world study of BTK inhibitors for the initial treatment of MYD88^mut/CD79B^mut diffuse large B‐cell lymphoma. Cancer Medicine. 13(4). e7005–e7005. 6 indexed citations

Song, Ge, Min Xiao, Xi Chen, et al.. (2024). Subdivision of M1 category and prognostic stage for de novo metastatic breast cancer to enhance prognostic prediction and guide the selection of locoregional therapy. Thoracic Cancer. 15(30). 2193–2205. 2 indexed citations

Xiao, Min, et al.. (2023). Platelet and ferritin as early predictive factors for the development of macrophage activation syndrome in children with Kawasaki disease: A retrospective case-control study. Frontiers in Pediatrics. 11. 1088525–1088525. 5 indexed citations

Du, Yu, Ying Wang, Xiaona Chang, et al.. (2023). Transformation to diffuse large B‐cell lymphoma and its impact on survival in patients with marginal zone lymphoma: A population‐based study. International Journal of Cancer. 154(6). 969–978. 6 indexed citations

10.

Jin, Jin, Ting Sun, Man Zhang, et al.. (2023). EBV-Encoded MicroRNA-BART17-3p Targets DDX3X and Promotes EBV Infection in EBV-Associated T/Natural Killer–Cell Lymphoproliferative Diseases. Open Forum Infectious Diseases. 10(11). ofad516–ofad516. 4 indexed citations

11.

Huang, Yang, et al.. (2023). Study of the Ecosystem Service Value Gradient at the Land–Water Interface Zone of the Xijiang River Mainstem. Applied Sciences. 13(18). 10485–10485.

12.

Adamopoulos, Christos, Tamer A. Ahmed, Maxwell R. Tucker, et al.. (2021). Exploiting Allosteric Properties of RAF and MEK Inhibitors to Target Therapy-Resistant Tumors Driven by Oncogenic BRAF Signaling. Cancer Discovery. 11(7). 1716–1735. 40 indexed citations

13.

Sharma, Samanta, Tian Zhang, Wojciech Michowski, et al.. (2020). Targeting the cyclin-dependent kinase 5 in metastatic melanoma. Proceedings of the National Academy of Sciences. 117(14). 8001–8012. 17 indexed citations

14.

Qiu, Xiaoyan, et al.. (2020). Effects of PXD101 and Embryo Aggregation on the In Vitro Development of Mouse Parthenogenetic Embryos. Cellular Reprogramming. 22(1). 14–21. 1 indexed citations

15.

Atay, Çiğdem, Taekyoung Kwak, Sergio Lavilla-Alonso, et al.. (2019). BRAF Targeting Sensitizes Resistant Melanoma to Cytotoxic T Cells. Clinical Cancer Research. 25(9). 2783–2794. 26 indexed citations

16.

Hammerlindl, Heinz, Dinoop Ravindran Menon, Abdullah Al Emran, et al.. (2017). Acetylsalicylic Acid Governs the Effect of Sorafenib in RAS -Mutant Cancers. Clinical Cancer Research. 24(5). 1090–1102. 15 indexed citations

17.

Krepler, Clemens, Srinivas K. Chunduru, Molly B. Halloran, et al.. (2013). The Novel SMAC Mimetic Birinapant Exhibits Potent Activity against Human Melanoma Cells. Clinical Cancer Research. 19(7). 1784–1794. 79 indexed citations

18.

Pinnix, Chelsea C., John Tayu Lee, Zhaojun Liu, et al.. (2009). Active Notch1 Confers a Transformed Phenotype to Primary Human Melanocytes. Cancer Research. 69(13). 5312–5320. 94 indexed citations

19.

Smalley, Keiran S.M., Mercedes Lioni, Maurizia Dalla Palma, et al.. (2008). Increased cyclin D1 expression can mediate BRAF inhibitor resistance in BRAF V600E–mutated melanomas. Molecular Cancer Therapeutics. 7(9). 2876–2883. 244 indexed citations

20.

Smalley, Keiran S.M., Rooha Contractor, Thiennga K. Nguyen, et al.. (2008). Identification of a Novel Subgroup of Melanomas with KIT/Cyclin-Dependent Kinase-4 Overexpression. Cancer Research. 68(14). 5743–5752. 82 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact